ST. LOUIS--(BUSINESS WIRE)--Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, will present research at the Crohn’s & ...
Picture this common clinical scenario: A patient has chronic diarrhea, abdominal pain, and weight loss. Blood and stool tests point to inflammatory bowel disease (IBD). But which one -- Crohn's ...
Carlsbad, CA, April 16, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel ...
WAS DIAGNOSED AFTER HAVING A BABY. AFTER HAVING A BABY, YOUR BODY CHANGES. BUT FOR ALISON MURDAUGH, SHE WENT TO THE DOCTOR AFTER REALIZING SOMETHING WASN’T QUITE RIGHT. SO THERE WAS SOME ABNORMAL ...
BERLIN — Anaerobic preparation and careful donor selection could be key to realizing the full potential of fecal microbiota transplantation (FMT) in ulcerative colitis (UC), according to results from ...
About three years ago, during my senior year of college, I started having health problems. I’d never really experienced digestive issues before, but I started seeing blood in my stool. It was so bad ...
Early-stage testing suggests that microbiota therapeutics like fecal transplants might one day help manage ulcerative colitis and Crohn’s disease. People with inflammatory bowel disease (IBD) who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback